The usual course of treatment for lymphatic tuberculosis is 6 to 9 months, possibly 1 to 2 years if infection with drug-resistant bacteria develops. The treatment of lymphatic tuberculosis is also generally divided into an intensive phase and a consolidation phase. The intensive phase is usually treated with a quadruple combination of anti-tuberculosis drugs, such as isoniazid, rifampicin, pyrazinamide, and ethambutol, and generally lasts 2 to 3 months. The consolidation phase of treatment, which usually takes 4 to 6 months, uses two combinations of anti-tuberculosis drugs such as isoniazid and rifampicin. It continues to destroy residual TB bacilli and to minimize and avoid the chances of recurrence. In case of infection with drug-resistant TB bacilli, second-line anti-tuberculosis drugs such as moxifloxacin and linezolid are required, potentially for 1 to 2 years. The course of TB treatment needs to be determined by the patient’s condition and is recommended to be used under the guidance of a specialist.